Remove digital ai-drug-discovery-day-two
article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Developing a new drug is a monumental achievement — the reward of years of research and innovation. AI in pharma R&D is one of the latest innovations helping teams apply existing knowledge to new problems. AI in pharma R&D is one of the latest innovations helping teams apply existing knowledge to new problems.

Pharma 52
article thumbnail

Marketer’s Crystal Ball: How Will the Industry Evolve Over the Next Few Years?

PM360

Perhaps no one can perfectly predict the future—or anticipate a global pandemic that is still having reverberations on our economy, our health, and the life sciences industry to this day—but. A key area emerging is the use of artificial intelligence (AI). Improving Engagement with AI. I recommend Prezent.AI Tyler Montague.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Industry Briefs April 2023

PM360

Grifols and Selagine Tackle Dry Eyes The two eyecare leaders have entered a research, development, and sublicense agreement to develop and commercialize immunoglobulin eye drops for dry eye disease. The eye drops are biological drugs that draw upon antibodies generated from human plasma collected from thousands of healthy donors.

article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

He’s the Chief Digital Officer for Health at Ogilvy. So I love talking to you because you’ve got your pulse on the finger of everything that’s happening digitally within healthcare, you always open my eyes to interesting things that are happening. And that reduces a time of drug discovery from 10 years to five years.

Pharma 52
article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

He’s the Chief Digital Officer for Health at Ogilvy. So I love talking to you because you’ve got your pulse on the finger of everything that’s happening digitally within healthcare, you always open my eyes to interesting things that are happening. And that reduces a time of drug discovery from 10 years to five years.

Pharma 40
article thumbnail

How pharma can thrive in the digital era

pharmaphorum

Food and Drug Administration’s (FDA) draft guidance, “ Digital Health Technologies for Remote Data Acquisition in Clinical Investigations ”. The Digital Medicine Society’s Library of Digital Endpoints surpassed 350 unique digital endpoints used for evaluating new medical products. Moving towards implementation.

Pharma 80
article thumbnail

Pioneering the next wave of LBP-based therapeutics

European Pharmaceutical Review

Although we have yet to understand the human microbiome and its role in disease fully, the scientific evidence on the efficacy of complex live biotherapeutic products (LBPs) in modulating the microbiome is striking, as evidenced by the approval of the first two commercial donor-derived products, Rebyota and VOWST, in 2022 and 2023, respectively.